Anti-CD47 therapy administered intratumorally to colon adenocarcinoma tumor (MC38)-bearing syngeneic WT C57BL/6 mice decreased tumor growth, but no effect was observed in T cell-deficient nude mice. This evidence concerns the gene CD47 and neoplasm.